Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non–Small Cell Lung Cancer

INTRODUCTION: With expanding indications for programmed death 1 (PD-1) axis inhibitors in non–small cell lung cancer (NSCLC), acquired resistance (AR) to these therapies is increasingly being encountered. We sought to characterize clinical patterns of AR to PD-1 axis inhibitors in patients with adva...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Thorac Oncol
Päätekijät: Gettinger, Scott N., Wurtz, Anna, Goldberg, Sarah B., Rimm, David, Schalper, Kurt, Kaech, Susan, Kavathas, Paula, Chiang, Anne, Lilenbaum, Rogerio, Zelterman, Daniel, Politi, Katerina, Herbst, Roy S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6485248/
https://ncbi.nlm.nih.gov/pubmed/29578107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2018.03.008
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia